Search Within

Alexandra Gewirtz

Formats
  1. Journal Article (10)
  2. Meeting Abstract (10)
  3. Review (1)
Groups
  1. GME, Neurology (21)
  2. Graduate Medical Education (21)
  3. Department of Medicine (20)
  4. Solid Tumor Oncology Division (19)
  5. Center for Pancreatic Cancer Research (17)
  6. Gastrointestinal Oncology Service (17)

More Groups

People
  1. Nancy Kemeny (17)
  2. Michael D'Angelica (13)
  3. William Jarnagin (13)
  4. Yuman Fong (12)
  5. Marinela Capanu (11)
  6. Ronald DeMatteo (10)

More People

Years
  1. 2024 (2)
  2. 2023 (2)
  3. 2015 (3)
  4. 2014 (4)
  5. 2013 (3)
  6. 2012 (1)

More Years

Publications
  1. Journal of Clinical Oncology (9)
  2. Cancer (2)
  3. HPB (2)
  4. Neuro-Oncology (2)
  5. Acta Neuropathologica Communications (1)
  6. Annals of Surgery (1)

More Publications

Publishers
  1. American Society of Clinical Oncology (9)
  2. Wiley Blackwell (3)
  3. Elsevier Science, Inc. (2)
  4. Oxford University Press (2)
  5. BioMed Central Ltd. (1)
  6. Elsevier Science Inc. (1)

More Publishers

Results (21)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Floxuridine hepatic arterial infusion associated biliary toxicity is increased by concurrent administration of systemic bevacizumab
    Journal Article

    Cercek, A.; D'Angelica, M.; Power, D.; Capanu, M.; Gewirtz, A.; Patel, D.; Allen, P.; Fong, Y.; DeMatteo, R. P.; Jarnagin, W. R.; more...
    Annals of Surgical Oncology (2014)

    Fulltext@MSK | Save
  • Influence of KRAS mutation on recurrence patterns in patients undergoing hepatic resection of colorectal metastases
    Meeting Abstract

    Kemeny, N. E.; Chou, J. F.; Capanu, M.; Gewirtz, A. N.; Cercek, A.; Kingham, T. P.; Jarnagin, W. R.; Fong, Y. M.; DeMatteo, R. P.; Allen, P. J.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Association of KRAS mutation with worse recurrence-free survival and site of metastatic progression after resection of hepatic colorectal metastases
    Meeting Abstract

    Kemeny, N. E.; Chou, J. F.; Capanu, M.; Gewirtz, A. N.; Cercek, A.; Kingham, T. P.; Jarnagin, W. R.; Fong, Y.; DeMatteo, R. P.; Allen, P. J.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Hepatic arterial infusion and systemic chemotherapy for breast cancer liver metastases
    Journal Article

    Ang, C.; Jhaveri, K.; Patel, D.; Gewirtz, A.; Seidman, A.; Kemeny, N.
    Breast Journal (2013)

    Fulltext@MSK | Save
  • Is conversion to resection possible with hepatic arterial infusion (HAI) and systemic (SYS) even in previously treated patients (pts) with unresectable colorectal liver metastases (UnCLM)?
    Meeting Abstract

    Kemeny, N. E.; Fong, Y.; Paty, P.; Chou, J. F.; Capanu, M.; Gewirtz, A. N.; Jarnagin, W. R.; DeMatteo, R. P.; Allen, P. J.; Kingham, T. P.; more...
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Treating primary liver cancer with hepatic arterial infusion of floxuridine and dexamethasone: Does the addition of systemic bevacizumab improve results?
    Meeting Abstract

    Kemeny, N. E.; Schwartz, L. H.; Gonen, M.; Yopp, A. C.; D'Angelica, M. I.; Fong, Y.; Haviland, D.; Gewirtz, A. N.; Allen, P. J.; Jarnagin, W. R.
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • Hepatic arterial infusion (HAI) in the treatment of breast cancer with liver metastases (BCLM) in patients (pts) who progressed after hormonal and systemic chemotherapy (CTx)
    Meeting Abstract

    Herran, L. A.; Jhaveri, K. L.; Seidman, A. D.; Patel, D.; Gewirtz, A. N.; Kemeny, N. E.
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • Treating primary liver cancer with hepatic arterial infusion of floxuridine and dexamethasone: Does the addition of systemic bevacizumab improve results?
    Journal Article

    Kemeny, N. E.; Schwartz, L.; Gonen, M.; Yopp, A.; Gultekin, D.; D'Angelica, M. I.; Fong, Y. M.; Haviland, D.; Gewirtz, A. N.; Allen, P.; more...
    Oncology (2011)

    Fulltext@MSK | Save
  • Randomized phase II trial of adjuvant hepatic arterial infusion and systemic chemotherapy with or without bevacizumab in patients with resected hepatic metastases from colorectal cancer
    Journal Article

    Kemeny, N. E.; Jarnagin, W. R.; Capanu, M.; Fong, Y.; Gewirtz, A. N.; DeMatteo, R. P.; D'Angelica, M. I.
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • Unexpected increased biliary toxicity when systemic bevacizumab is added to hepatic arterial infusion
    Meeting Abstract

    Power, D. G.; Capanu, M.; Patel, D.; Gewirtz, A.; Jarnagin, W. R.; Fong, Y.; D'Angelica, M. I.; DeMatteo, R. P.; Kemeny, N. E.
    Journal of Clinical Oncology (2010)

    Fulltext@MSK | Save